Across TCGA pan-cancer cohorts, WBP1LP4 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated WBP1LP4 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher WBP1LP4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated WBP1LP4 expression acts as an unfavorable survival marker.
UVM and GBM are the cancer types where WBP1LP4 RNA most reproducibly stratifies survival.